Pelubiprofen CR Tablet (Controlled Release)
Formulation (FDF) · Tablet · 45mg, twice daily
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Pelubiprofen CR Tablet (Controlled Release)
- Dosage Form
- Tablet
- Strength
- 45mg, twice daily
- Therapy Area
- Others > Rheumatology
- Indication
- Pain; Osteoarthritis; Low back pain; Rheumatoid arthritis
- Current Status
- Official FDF licensing catalog (UB417)
- GMP Certification
- KR - MFDS
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
South Korea
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price